Roche and Spark Therapeutics, Inc. announce extension of tender offer for shares of Spark Therapeutics, Inc.

    NEXT STORY
    ASLAN Pharmaceuticals Announces Publication of Preclinical Data on ASLAN003 in AML in Haematologica Journal
    PREV STORY
    Progenics Pharmaceuticals Appoints David Mims as Interim Chief Executive Officer
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Summit Discovers Multiple New Mechanism Antibiotics Against Novel ESKAPE Pathogen Targets

    Summit Therapeutics plc  (‘Summit’ or the ’Company’)Summit Discovers Multiple New Mechanism Antibiotics Against Novel ...

    author_avatar
    NASDAQ Market News

    Roche Purchases Shares in Tender Offer for FMI

    Basel, 31 July 2018 - Roche (SIX: RO, ROG; OTCQX: RHHBY) and Foundation Medicine, ...

    author_avatar
    NASDAQ Market News

    Oligonucleotide Synthesis Market Size to Cross $2.8 Billion by 2023: P&S Market Research

    NEW YORK, May 29, 2018 (GLOBE NEWSWIRE) -- According to the market research report ...

    author_avatar
    NASDAQ Market News